Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
Status:
Not yet recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
To evaluate if the combination of pivmecillinam and clavulanic acid (PAC) is non-inferior to
ciprofloxacin or trimethoprim-sulfamethoxazole as step down oral therapy in patients with
febrile UTI caused by extended spectrum beta-lactamase (ESBL) producing Enterobacterales
(EPE).